Companies in #Pancreatic cancer
Found 2 companies operating in this sector.
Novocure (NASDAQ: NVCR) is an oncology medical-device company pioneering Tumor Treating Fields (TTFields), a non-invasive, antimitotic therapy delivered via wearable transducer arrays. Approved for glioblastoma (Optune Gio) and malignant pleural mesothelioma, with active programs in non-small cell lung cancer, pancreatic cancer, brain metastases, and ovarian cancer.
Verastem Oncology is a commercial-stage biopharmaceutical company (NASDAQ: VSTM) developing medicines to improve the lives of patients with cancer, with a focus on RAS/MAPK pathway-driven tumors and hematologic cancers. Lead marketed product is Avmapki Fakzynja Co-Pack (avutometinib + defactinib) for KRAS-mutated recurrent low-grade serous ovarian cancer.